Targeting GPR34 in damage-associated macrophages enhances anti-tumor immunity and the efficacy of Surufatinib in pancreatic cancer
Guo Xiaofan, Liu Yuxiao, Li Tianchen, An Xiaopeng, Song Yuning, Xu Peijun, Huang Jing, Zou Yiping, Xu Bohang, Xie Yongjie, Li Zekun, Meng Chenyang, Zhao Tiansuo, Wang Xiuchao, Wang Hongwei, Gao Chuntao, Zhou Xuan, Yu Jun, Gao Song, Hao Jihui
期刊：Signal Transduction and Targeted Therapy
发表时间：2026-04-27
DOI：10.1038/s41392-026-02641-4
影响因子：81.2
研究领域：肿瘤研究
引用产品：2×HEPES缓冲液（pH7.2-7.4）/H1080玉米油/C7030青霉素-链霉素-两性霉素B混合溶液（100×）/P7630曲拉通 Triton X-100/T8200
销售顾问慧慧
销售顾问俊俊